Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices
NHS hospitals in England used £339,886,764 of indicative cost of Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 1.3% of all hospital medicines spend. That is down 37.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Norfolk & Norwich University Hpl Nhs Trt | £14,503,283 |
| Oxford University Hospitals Nhs Ft | £12,252,168 |
| Royal Free London Nhs Foundation Trust | £11,569,951 |
| South Tees Hosp Nhs Foundation Trust | £11,089,185 |
| Royal Cornwall Hospitals Nhs Trust | £11,068,684 |
| Salford Royal Nhs Foundation Trust | £9,501,315 |
| Guy's & St Thomas' Nhs Foundation Trust | £8,954,172 |
| Imperial College Healthcare Nhs Trust | £8,761,916 |
| University Hospitals Plymouth Nhs Trust | £8,744,561 |
| University Hospitals Dorset Nhs Ft | £8,658,747 |
The primary-care picture
Adalimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Adalimumab medicine page.